Clinical Trials Browser

Recruiting × Immune System Diseases × Genitourinary × Clear all

Mesothelioma, Malignant, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Endometrial Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT05318196 2024-03-29

NEPHROGENE2

Recruiting

5,000 enrolled

Genitourinary

Immune System Diseases, Metabolic Diseases, Neoplasms, Renal Insufficiency, Chronic, Acute Kidney Injury

Clinical Trials

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

NEPHROGENE2